Selected research
Industry Growth & Trends
Global Nystatin Industry Growth and Trends Forecast to 2032
Market perspective
The global Nystatin market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Nystatin is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Nystatin is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Nystatin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Nystatin include 3B Scientific, BeiJing Hwrk Chemicals, Beijing NuoqiYa Biotechnology, BEST-REAGENT, BOC Sciences, Fishfa Biogenics, HBCChem, J & K SCIENTIFIC and LGM Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Nystatin market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Nystatin market size, estimates, and forecasts are presented in terms of sales volume (t) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Nystatin market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Nystatin.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Nystatin market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Nystatin Market by Company
3B Scientific
BeiJing Hwrk Chemicals
Beijing NuoqiYa Biotechnology
BEST-REAGENT
BOC Sciences
Fishfa Biogenics
HBCChem
J & K SCIENTIFIC
LGM Pharma
Pure Chemistry Scientific
Toronto Research Chemicals
Waterstone Technology
XiaoGan ShenYuan ChemPharm
Olon S.p.A
Guangzhou Tosun Pharmaceutical
Pfizer
Concord Biotech
BrightGene Bio-Medical Technology
Antibiotice SA
Shanghai Minbiotech
Zhejiang Huida Biotech
Centrient Pharmaceuticals
Nystatin Segment by Type
USP Grade
Research Grade
Others
Nystatin Segment by Application
Skin
Oral Cavity
Others
Nystatin Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nystatin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Nystatin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nystatin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nystatin manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Nystatin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- USP Grade
- Research Grade
- Others
Applications
- Skin
- Oral Cavity
- Others
Companies covered
- 3B Scientific
- BeiJing Hwrk Chemicals
- Beijing NuoqiYa Biotechnology
- BEST-REAGENT
- BOC Sciences
- Fishfa Biogenics
- HBCChem
- J & K SCIENTIFIC
- LGM Pharma
- Pure Chemistry Scientific
- Toronto Research Chemicals
- Waterstone Technology
- XiaoGan ShenYuan ChemPharm
- Olon S.p.A
- Guangzhou Tosun Pharmaceutical
- Pfizer
- Concord Biotech
- BrightGene Bio-Medical Technology
- Antibiotice SA
- Shanghai Minbiotech
- Zhejiang Huida Biotech
- Centrient Pharmaceuticals
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Nystatin Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Nystatin Sales Estimates and Forecasts (2021-2032)
- 1.3 Nystatin Market by Type
- 1.3.1 USP Grade
- 1.3.2 Research Grade
- 1.3.3 Others
- 1.4 Global Nystatin Market Size by Type
- 1.4.1 Global Nystatin Market Size Overview by Type (2021-2032)
- 1.4.2 Global Nystatin Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Nystatin Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Nystatin Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Nystatin Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Nystatin Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Nystatin Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Nystatin Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Nystatin Industry Trends
- 2.2 Nystatin Industry Drivers
- 2.3 Nystatin Industry Opportunities and Challenges
- 2.4 Nystatin Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Nystatin Revenue (2021-2026)
- 3.2 Global Top Players by Nystatin Sales (2021-2026)
- 3.3 Global Top Players by Nystatin Price (2021-2026)
- 3.4 Global Nystatin Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Nystatin Major Company Production Sites & Headquarters
- 3.6 Global Nystatin Company, Product Type & Application
- 3.7 Global Nystatin Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Nystatin Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Nystatin Players Market Share by Revenue in 2025
- 3.8.3 2025 Nystatin Tier 1, Tier 2, and Tier 3
4 Nystatin Regional Status and Outlook
- 4.1 Global Nystatin Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Nystatin Historic Market Size by Region
- 4.2.1 Global Nystatin Sales in Volume by Region (2021-2026)
- 4.2.2 Global Nystatin Sales in Value by Region (2021-2026)
- 4.2.3 Global Nystatin Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Nystatin Forecasted Market Size by Region
- 4.3.1 Global Nystatin Sales in Volume by Region (2027-2032)
- 4.3.2 Global Nystatin Sales in Value by Region (2027-2032)
- 4.3.3 Global Nystatin Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Nystatin by Application
- 5.1 Nystatin Market by Application
- 5.1.1 Skin
- 5.1.2 Oral Cavity
- 5.1.3 Others
- 5.2 Global Nystatin Market Size by Application
- 5.2.1 Global Nystatin Market Size Overview by Application (2021-2032)
- 5.2.2 Global Nystatin Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Nystatin Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Nystatin Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Nystatin Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Nystatin Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Nystatin Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Nystatin Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 3B Scientific
- 6.1.1 3B Scientific Company Information
- 6.1.2 3B Scientific Business Overview
- 6.1.3 3B Scientific Nystatin Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 3B Scientific Nystatin Product Portfolio
- 6.1.5 3B Scientific Recent Developments
- 6.2 BeiJing Hwrk Chemicals
- 6.2.1 BeiJing Hwrk Chemicals Company Information
- 6.2.2 BeiJing Hwrk Chemicals Business Overview
- 6.2.3 BeiJing Hwrk Chemicals Nystatin Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 BeiJing Hwrk Chemicals Nystatin Product Portfolio
- 6.2.5 BeiJing Hwrk Chemicals Recent Developments
- 6.3 Beijing NuoqiYa Biotechnology
- 6.3.1 Beijing NuoqiYa Biotechnology Company Information
- 6.3.2 Beijing NuoqiYa Biotechnology Business Overview
- 6.3.3 Beijing NuoqiYa Biotechnology Nystatin Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Beijing NuoqiYa Biotechnology Nystatin Product Portfolio
- 6.3.5 Beijing NuoqiYa Biotechnology Recent Developments
- 6.4 BEST-REAGENT
- 6.4.1 BEST-REAGENT Company Information
- 6.4.2 BEST-REAGENT Business Overview
- 6.4.3 BEST-REAGENT Nystatin Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 BEST-REAGENT Nystatin Product Portfolio
- 6.4.5 BEST-REAGENT Recent Developments
- 6.5 BOC Sciences
- 6.5.1 BOC Sciences Company Information
- 6.5.2 BOC Sciences Business Overview
- 6.5.3 BOC Sciences Nystatin Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 BOC Sciences Nystatin Product Portfolio
- 6.5.5 BOC Sciences Recent Developments
- 6.6 Fishfa Biogenics
- 6.6.1 Fishfa Biogenics Company Information
- 6.6.2 Fishfa Biogenics Business Overview
- 6.6.3 Fishfa Biogenics Nystatin Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Fishfa Biogenics Nystatin Product Portfolio
- 6.6.5 Fishfa Biogenics Recent Developments
- 6.7 HBCChem
- 6.7.1 HBCChem Company Information
- 6.7.2 HBCChem Business Overview
- 6.7.3 HBCChem Nystatin Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 HBCChem Nystatin Product Portfolio
- 6.7.5 HBCChem Recent Developments
- 6.8 J & K SCIENTIFIC
- 6.8.1 J & K SCIENTIFIC Company Information
- 6.8.2 J & K SCIENTIFIC Business Overview
- 6.8.3 J & K SCIENTIFIC Nystatin Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 J & K SCIENTIFIC Nystatin Product Portfolio
- 6.8.5 J & K SCIENTIFIC Recent Developments
- 6.9 LGM Pharma
- 6.9.1 LGM Pharma Company Information
- 6.9.2 LGM Pharma Business Overview
- 6.9.3 LGM Pharma Nystatin Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 LGM Pharma Nystatin Product Portfolio
- 6.9.5 LGM Pharma Recent Developments
- 6.10 Pure Chemistry Scientific
- 6.10.1 Pure Chemistry Scientific Company Information
- 6.10.2 Pure Chemistry Scientific Business Overview
- 6.10.3 Pure Chemistry Scientific Nystatin Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Pure Chemistry Scientific Nystatin Product Portfolio
- 6.10.5 Pure Chemistry Scientific Recent Developments
- 6.11 Toronto Research Chemicals
- 6.11.1 Toronto Research Chemicals Company Information
- 6.11.2 Toronto Research Chemicals Business Overview
- 6.11.3 Toronto Research Chemicals Nystatin Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Toronto Research Chemicals Nystatin Product Portfolio
- 6.11.5 Toronto Research Chemicals Recent Developments
- 6.12 Waterstone Technology
- 6.12.1 Waterstone Technology Company Information
- 6.12.2 Waterstone Technology Business Overview
- 6.12.3 Waterstone Technology Nystatin Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 Waterstone Technology Nystatin Product Portfolio
- 6.12.5 Waterstone Technology Recent Developments
- 6.13 XiaoGan ShenYuan ChemPharm
- 6.13.1 XiaoGan ShenYuan ChemPharm Company Information
- 6.13.2 XiaoGan ShenYuan ChemPharm Business Overview
- 6.13.3 XiaoGan ShenYuan ChemPharm Nystatin Sales, Revenue and Gross Margin (2021-2026)
- 6.13.4 XiaoGan ShenYuan ChemPharm Nystatin Product Portfolio
- 6.13.5 XiaoGan ShenYuan ChemPharm Recent Developments
- 6.14 Olon S.p.A
- 6.14.1 Olon S.p.A Company Information
- 6.14.2 Olon S.p.A Business Overview
- 6.14.3 Olon S.p.A Nystatin Sales, Revenue and Gross Margin (2021-2026)
- 6.14.4 Olon S.p.A Nystatin Product Portfolio
- 6.14.5 Olon S.p.A Recent Developments
- 6.15 Guangzhou Tosun Pharmaceutical
- 6.15.1 Guangzhou Tosun Pharmaceutical Company Information
- 6.15.2 Guangzhou Tosun Pharmaceutical Business Overview
- 6.15.3 Guangzhou Tosun Pharmaceutical Nystatin Sales, Revenue and Gross Margin (2021-2026)
- 6.15.4 Guangzhou Tosun Pharmaceutical Nystatin Product Portfolio
- 6.15.5 Guangzhou Tosun Pharmaceutical Recent Developments
- 6.16 Pfizer
- 6.16.1 Pfizer Company Information
- 6.16.2 Pfizer Business Overview
- 6.16.3 Pfizer Nystatin Sales, Revenue and Gross Margin (2021-2026)
- 6.16.4 Pfizer Nystatin Product Portfolio
- 6.16.5 Pfizer Recent Developments
- 6.17 Concord Biotech
- 6.17.1 Concord Biotech Company Information
- 6.17.2 Concord Biotech Business Overview
- 6.17.3 Concord Biotech Nystatin Sales, Revenue and Gross Margin (2021-2026)
- 6.17.4 Concord Biotech Nystatin Product Portfolio
- 6.17.5 Concord Biotech Recent Developments
- 6.18 BrightGene Bio-Medical Technology
- 6.18.1 BrightGene Bio-Medical Technology Company Information
- 6.18.2 BrightGene Bio-Medical Technology Business Overview
- 6.18.3 BrightGene Bio-Medical Technology Nystatin Sales, Revenue and Gross Margin (2021-2026)
- 6.18.4 BrightGene Bio-Medical Technology Nystatin Product Portfolio
- 6.18.5 BrightGene Bio-Medical Technology Recent Developments
- 6.19 Antibiotice SA
- 6.19.1 Antibiotice SA Company Information
- 6.19.2 Antibiotice SA Business Overview
- 6.19.3 Antibiotice SA Nystatin Sales, Revenue and Gross Margin (2021-2026)
- 6.19.4 Antibiotice SA Nystatin Product Portfolio
- 6.19.5 Antibiotice SA Recent Developments
- 6.20 Shanghai Minbiotech
- 6.20.1 Shanghai Minbiotech Company Information
- 6.20.2 Shanghai Minbiotech Business Overview
- 6.20.3 Shanghai Minbiotech Nystatin Sales, Revenue and Gross Margin (2021-2026)
- 6.20.4 Shanghai Minbiotech Nystatin Product Portfolio
- 6.20.5 Shanghai Minbiotech Recent Developments
- 6.21 Zhejiang Huida Biotech
- 6.21.1 Zhejiang Huida Biotech Company Information
- 6.21.2 Zhejiang Huida Biotech Business Overview
- 6.21.3 Zhejiang Huida Biotech Nystatin Sales, Revenue and Gross Margin (2021-2026)
- 6.21.4 Zhejiang Huida Biotech Nystatin Product Portfolio
- 6.21.5 Zhejiang Huida Biotech Recent Developments
- 6.22 Centrient Pharmaceuticals
- 6.22.1 Centrient Pharmaceuticals Company Information
- 6.22.2 Centrient Pharmaceuticals Business Overview
- 6.22.3 Centrient Pharmaceuticals Nystatin Sales, Revenue and Gross Margin (2021-2026)
- 6.22.4 Centrient Pharmaceuticals Nystatin Product Portfolio
- 6.22.5 Centrient Pharmaceuticals Recent Developments
7 North America by Country
- 7.1 North America Nystatin Sales by Country
- 7.1.1 North America Nystatin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Nystatin Sales by Country (2021-2026)
- 7.1.3 North America Nystatin Sales Forecast by Country (2027-2032)
- 7.2 North America Nystatin Market Size by Country
- 7.2.1 North America Nystatin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Nystatin Market Size by Country (2021-2026)
- 7.2.3 North America Nystatin Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Nystatin Sales by Country
- 8.1.1 Europe Nystatin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Nystatin Sales by Country (2021-2026)
- 8.1.3 Europe Nystatin Sales Forecast by Country (2027-2032)
- 8.2 Europe Nystatin Market Size by Country
- 8.2.1 Europe Nystatin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Nystatin Market Size by Country (2021-2026)
- 8.2.3 Europe Nystatin Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Nystatin Sales by Country
- 9.1.1 Asia-Pacific Nystatin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Nystatin Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Nystatin Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Nystatin Market Size by Country
- 9.2.1 Asia-Pacific Nystatin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Nystatin Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Nystatin Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Nystatin Sales by Country
- 10.1.1 South America Nystatin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Nystatin Sales by Country (2021-2026)
- 10.1.3 South America Nystatin Sales Forecast by Country (2027-2032)
- 10.2 South America Nystatin Market Size by Country
- 10.2.1 South America Nystatin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Nystatin Market Size by Country (2021-2026)
- 10.2.3 South America Nystatin Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Nystatin Sales by Country
- 11.1.1 Middle East and Africa Nystatin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Nystatin Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Nystatin Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Nystatin Market Size by Country
- 11.2.1 Middle East and Africa Nystatin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Nystatin Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Nystatin Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Nystatin Value Chain Analysis
- 12.1.1 Nystatin Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Nystatin Production Mode & Process
- 12.2 Nystatin Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Nystatin Distributors
- 12.2.3 Nystatin Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst